A new report shows that cancer cases are increasing in females in the United States and in younger adults. For the first time ...

People often let chronic conditions such as high blood pressure and diabetes go for a long time without treatment. Here’s why ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Understanding the definition of obesity: experts examine the limitations of body-mass index (BMI) and propose alternative measures for adiposity.

In a westward expansion, FreezPak Logistics is taking up residence in its first West Coast facility: a new cold storage ...

The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs, for the second annual round of drug price ...

Now that the US Food and Drug Administration has banned red dye No. 3, many people are criticizing or questioning the safety ...

Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...